We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Advanced Medical Solutions Group Plc | LSE:AMS | London | Ordinary Share | GB0004536594 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.80 | 1.49% | 190.40 | 189.20 | 190.40 | 192.00 | 187.40 | 189.20 | 284,402 | 16:35:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Plastics,resins,elastomers | 126.21M | 15.89M | 0.0732 | 25.85 | 410.96M |
TIDMAMS
RNS Number : 6157J
Advanced Medical Solutions Grp PLC
29 June 2017
29 June 2017
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR and PCA Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that it was notified on 26 June 2017 that Chris Meredith, who is a Director and PDMR, following the successful achievement of certain performance criteria, has exercised 162,069 options from the Long Term Incentive Plan (LTIP). Mr Meredith subsequently sold 76,604 Ordinary Shares of 5p each on 26 June 2017 at a share price of 301.8015p per Ordinary Share to cover the tax payable on this exercise.
As a result of these transactions Chris Meredith's beneficial interest in the Company has increased from 1,384,841 shares to 1,470,306 shares.
Long Term Incentive Plan (LTIP)
Director No. of LTIPs Ordinary Ordinary LTIPs LTIPs prior exercised Shares shares after to exercise sold retained exercise ------------------ ------------- ----------- --------- ---------- ---------- Chris Meredith, Chief Executive Officer 583,509 162,069 76,604 85,465 421,440 ------------------ ------------- ----------- --------- ---------- ----------
Overall Holding
Director Holding Number Number Sale Resultant % of prior of shares of shares price holding issued to exercise exercised sold (p) share capital ----------------- ------------- ----------- ----------- ---------- ---------- --------- Chris Meredith, Chief Executive Officer 1,384,841 162,069 76,604 301.8015p 1,470,306 0.69% ----------------- ------------- ----------- ----------- ---------- ---------- ---------
The Company further announces that it was notified on 26 June 2017 that Mary Tavener, who is a Director and PDMR, following the successful achievement of certain performance criteria, has exercised 162,069 options from the Long Term Incentive Plan (LTIP). Mrs Tavener subsequently sold 54,519 Ordinary Shares of 5p each on 26 June 2017 at a share price of 301.8015p per Ordinary Share to cover the tax payable on this exercise.
As a result of these transactions Mary Tavener's beneficial interest in the Company has increased from 1,890,647 shares to 1,954,191 shares.
Long Term Incentive Plan (LTIP)
Director No. of LTIPs Ordinary Ordinary LTIPs LTIPs prior exercised Shares shares after to exercise sold retained exercise ------------------ ------------- ----------- --------- ---------- ---------- Mary Tavener, Chief Financial Officer 442,265 114,440 54,519 63,544 327,825 ------------------ ------------- ----------- --------- ---------- ----------
Overall Holding
Director Holding Number Number Sale Resultant % of prior of shares of shares price holding issued to exercise exercised sold (p) share capital --------------- ------------- ----------- ----------- ---------- ---------- --------- Mary Tavener, Chief Financial Officer 1,890,647 114,440 54,519 301.8015p 1,954,191 0.92% --------------- ------------- ----------- ----------- ---------- ---------- ---------
The Company further announces that it was notified on 26 June 2017 that Jeff Willis, who is a Senior Manager and PDMR, following the successful achievement of certain performance criteria, has exercised 38,450 options from the Long Term Incentive Plan (LTIP). Following this transaction the beneficial ownership of Jeff Willis is as follows:
Long Term Incentive Plan (LTIP)
PDMR No. of LTIPs LTIPs exercised Ordinary LTIPs after prior to shares exercise exercise retained ------------- ------------- ---------------- ---------- ------------ Jeff Willis 161,044 38,450 38,450 122,594 ------------- ------------- ---------------- ---------- ------------
Overall Holding
PDMR Holding Number of Resultant % of issued prior to shares exercised holding share exercise capital ------------- ---------- ------------------ ---------- ------------ Jeff Willis 130,085 38,450 168,535 0.08% ------------- ---------- ------------------ ---------- ------------
The Company further announces that it was notified on 26 June 2017 that Simon Coates, who is a Senior Manager and PDMR, following the successful achievement of certain performance criteria, has exercised 27,783 options from the Long Term Incentive Plan (LTIP). Mr Coates has also exercised 7,888 Ordinary Shares of 5p from the Deferred Share Bonus Plan (DSB). Mr Coates subsequently sold 17,448 Ordinary Shares of 5p each on 26 June 2017 at a share price of 301.8015p per Ordinary Share to cover the tax payable on these exercises.
Following these transactions the beneficial ownership of Simon Coates is as follows:
Long Term Incentive Plan (LTIP)
PDMR No. of LTIPs LTIPs exercised Ordinary LTIPs after prior to shares exercise exercise retained -------------- ------------- ---------------- ---------- ------------ Simon Coates 101,409 27,783 10,335 73,626 -------------- ------------- ---------------- ---------- ------------
Deferred Share Bonus Plan (DSB)
PDMR No. of DSBs exercised Ordinary DSBs after DSBs prior Shares exercise to exercise sold -------------- ------------- --------------- --------- ----------- Simon Coates 42,825 7,888 Nil 34,937 -------------- ------------- --------------- --------- -----------
Overall Holding
PDMR Holding Number of Number Sale Resultant % of issued prior shares exercised of shares price holding share to exercise sold (p) capital --------- ------------- ------------------ ----------- ---------- ---------- ------------ Simon Coates 73,481 35,671 17,448 301.8015p 91,704 0.04% --------- ------------- ------------------ ----------- ---------- ---------- ------------
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. Details of the person discharging managerial responsibilities/person closely associated --- -------------------------------------------------------- a) Name: Chris Meredith --- -------------------------------------------------------- 2. Reason for the notification --- -------------------------------------------------------- a) Position/status: Director/PDMR --- -------------------------------------------------------- b) Initial notification/Amendment: Initial Notification --- -------------------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- -------------------------------------------------------- a) Name: Advanced Medical Solutions Group plc --- -------------------------------------------------------- b) LEI: 213800HJP6OWOSZI1L74 --- -------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- -------------------------------------------------------- a) Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 --- -------------------------------------------------------- b) Nature of the transactions: * Exercise of 162,069 shares from the Long Term Incentive Plan * Sale of 76,604 Ordinary Shares of 5p --- -------------------------------------------------------- c) Price(s) and volume(s): Sale of shares: Price(s) Volume(s) ------------- ---------- GBP3.018015 76,604 ------------- ---------- --- -------------------------------------------------------- d) Aggregated information: (Relates to those shares sold only) Aggregated volume: 76,604 Aggregated price: GBP3.018015 --- -------------------------------------------------------- e) Date of the transaction: 26/06/2017 --- -------------------------------------------------------- f) Place of the transaction: London Stock Exchange, AIM Market (XLON) --- --------------------------------------------------------
1. Details of the person discharging managerial responsibilities/person closely associated --- -------------------------------------------------------- a) Name: Mary Tavener --- -------------------------------------------------------- 2. Reason for the notification --- -------------------------------------------------------- a) Position/status: Director/PDMR --- -------------------------------------------------------- b) Initial notification/Amendment: Initial Notification --- -------------------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- -------------------------------------------------------- a) Name: Advanced Medical Solutions Group plc --- -------------------------------------------------------- b) LEI: 213800HJP6OWOSZI1L74 --- -------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- -------------------------------------------------------- a) Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 --- -------------------------------------------------------- b) Nature of the transactions: * Exercise of 199,319 shares from the Long Term Incentive Plan * Sale of 148,423 Ordinary Shares of 5p --- -------------------------------------------------------- c) Price(s) and volume(s): Sale of shares: Price(s) Volume(s) ------------- ---------- GBP3.018015 54,519 ------------- ---------- --- -------------------------------------------------------- d) Aggregated information: (Relates to those shares sold only) Aggregated volume: 54,519 Aggregated price: GBP3.018015 --- -------------------------------------------------------- e) Date of the transaction: 26/06/2017 --- -------------------------------------------------------- f) Place of the transaction: London Stock Exchange, AIM Market (XLON) --- -------------------------------------------------------- 1. Details of the person discharging managerial responsibilities/person closely associated --- ------------------------------------------------------- a) Name: Jeff Willis --- ------------------------------------------------------- 2. Reason for the notification --- ------------------------------------------------------- a) Position/status: Senior Manager/PDMR --- ------------------------------------------------------- b) Initial notification/Amendment: Initial Notification --- ------------------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------- a) Name: Advanced Medical Solutions Group plc --- ------------------------------------------------------- b) LEI: 213800HJP6OWOSZI1L74 --- ------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------- a) Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 --- ------------------------------------------------------- b) Nature of the transaction: * Exercise of 38,450 shares from the Long Term Incentive Plan --- ------------------------------------------------------- c) Price(s) and volume(s): Sale of shares: Price(s) Volume(s) --------- ---------- n/a n/a --------- ---------- --- ------------------------------------------------------- d) Aggregated information: (Relates to those shares sold only) Aggregated volume: n/a Aggregated price: n/a --- ------------------------------------------------------- e) Date of the transaction: 26/06/2017 --- ------------------------------------------------------- f) Place of the transaction: London Stock Exchange, AIM Market (XLON) --- ------------------------------------------------------- 1. Details of the person discharging managerial responsibilities/person closely associated --- ----------------------------------------------------------- a) Name: Simon Coates --- ----------------------------------------------------------- 2. Reason for the notification --- ----------------------------------------------------------- a) Position/status: Senior Manager/PDMR --- ----------------------------------------------------------- b) Initial notification/Amendment: Initial Notification --- ----------------------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ----------------------------------------------------------- a) Name: Advanced Medical Solutions Group plc --- ----------------------------------------------------------- b) LEI: 213800HJP6OWOSZI1L74 --- ----------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ----------------------------------------------------------- a) Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 --- ----------------------------------------------------------- b) Nature of the transactions: * Exercise of 27,783 shares from the Long Term Incentive Plan * Exercise of 7,888 shares from the Deferred Share Bonus Plan * Sale of 17,448 Ordinary Shares of 5p --- ----------------------------------------------------------- c) Price(s) and volume(s): Sale of shares: Price(s) Volume(s) ------------- ---------- GBP3.018015 17,448 ------------- ---------- --- ----------------------------------------------------------- d) Aggregated information: (Relates to those shares sold only) Aggregated volume: 17,448 Aggregated price: GBP3.018015 --- ----------------------------------------------------------- e) Date of the transaction: 26/06/2017 --- ----------------------------------------------------------- f) Place of the transaction: London Stock Exchange, AIM Market (XLON) --- -----------------------------------------------------------
-End -
For further information, please visit www.admedsol.com or contact:
Advanced Medical Solutions Group Tel: +44 (0) plc 1606 545508 Chris Meredith, Chief Executive Officer Mary Tavener, Chief Financial Officer Consilium Strategic Communications Tel: +44 (0) 20 3709 5700 Mary-Jane Elliott / Jonathan AMS@consilium-comms.com Birt / Matthew Neal / Hendrik Thys Investec Bank plc(NOMAD & Broker) Tel: +44 (0) 20 7597 5970 Daniel Adams / Patrick Robb
About Advanced Medical Solutions Group plc - see www.admedsol.com
AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and advanced wound care markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of wound care products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it sells under white label as well as its own brand ActivHeal(R) , and surgical tissue adhesives, sutures and haemostats, which markets under its own brands; LiquiBand(R) and RESORBA(R) .
AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Company has 600 employees. For more information, please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLLFEFRLIAFID
(END) Dow Jones Newswires
June 29, 2017 08:53 ET (12:53 GMT)
1 Year Advanced Medical Solutions Chart |
1 Month Advanced Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions